Search CCR News:
Below are links to NCI press releases that highlight new advances in basic, clinical,
and translational science at the Center for Cancer Research.
NCI Press Release
(Posted: 5/8/2014) - A new method for using immunotherapy to specifically attack tumor cells that have mutations unique to a patient's cancer has been developed by NCI scientists.
NCI News Note
(Posted: 4/14/2014) - Aberrant expression of an inflammatory protein, nitric oxide synthase 2 (NOS2), may enhance the progression and metastasis of an aggressive and less common form of breast cancer, known as the estrogen receptor-negative type of disease.
NCI Perspective Article
(Posted: 4/7/2014) - This year's American Association for Cancer Research meeting featured plenary talks by two NCI scientists, Steven Rosenberg, M.D., and Louis Staudt, M.D., Ph.D., that highlighted the challenges in developing varied and potentially synergistic treatments for aggressive forms of cancer. Each researcher has been focusing primarily on a particularly difficult to treat cancer (melanoma and lymphoma, respectively) for many decades, and their presentations highlight the diligence and tenacity needed to come to a better understanding of the cancer process and to find effective agents to target the diseases they study.
NCI Press Release
(Posted: 1/23/2014) - Scientists have mapped the genetic changes that drive tumors in rhabdomyosarcoma, a pediatric soft-tissue cancer, and found that the disease is characterized by two distinct genotypes. The genetic alterations identified in this malignancy could be useful in developing targeted diagnostic tools and treatments for children with the disease.
A service of the National Cancer Institute